Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr;26(4):375-381.
doi: 10.18553/jmcp.2020.19372. Epub 2020 Mar 4.

Top Evidentiary Gaps in Managed Care Pharmacy: A Research Agenda

Affiliations

Top Evidentiary Gaps in Managed Care Pharmacy: A Research Agenda

Jody Gembarski et al. J Manag Care Spec Pharm. 2020 Apr.

Abstract

Research agendas play valuable roles in clearly identifying high-priority topics that reflect potential to improve health care quality. The purpose of this report is to present work completed by the Academy of Managed Care Pharmacy (AMCP) and AMCP Foundation Joint Research Committee. This committee set forth to develop a research agenda for our 2 organizations that focuses on critical evidence needs in managed care pharmacy. This document reviews results from 2 surveys that were conducted to better understand unmet research needs within managed care pharmacy and to inform professional efforts of managed care pharmacists. The first survey collected qualitative data from key opinion leaders (KOLs) regarding the top evidentiary gaps in managed care pharmacy and barriers to closing those gaps. The second survey was sent to AMCP members and AMCP Foundation stakeholders, used a mixed methods quantitative-qualitative design, and incorporated concepts from initial KOL responses. The key outcome from these proceedings is the research agenda, which identifies and prioritizes 4 evidentiary gaps in managed care pharmacy: (1) real-world evidence to inform managed care pharmacy decision making, (2) value-based models in managed care pharmacy to address total cost of care, (3) impact of benefit design or utilization management strategies on patient outcomes, and (4) impact of direct patient care services provided by managed care pharmacy on patient outcomes. The agenda was intended to be broad and will evolve over time. AMCP and the AMCP Foundation hope that this research agenda inspires the AMCP membership, researchers, and funding agencies to close these gaps in knowledge and understanding. DISCLOSURES: Chairs and members of the Joint Research Committee oversaw and conducted the work outlined in this report with the support of AMCP and the AMCP Foundation. No outside funding was received. Gembarski, Couto, Wilson, and Eichenbrenner declare no conflicts of interest, real or apparent, with any product or service mentioned in this report. Gembarski is employed by BCBS Michigan; Couto is employed by Cigna; Wilson is employed by HealthCore, a wholly owned subsidiary of Anthem; and Eichenbrenner is employed by the AMCP Foundation.

PubMed Disclaimer

Conflict of interest statement

Chairs and members of the Joint Research Committee oversaw and conducted the work outlined in this report with the support of AMCP and the AMCP Foundation. No outside funding was received. Gembarski, Couto, Wilson, and Eichenbrenner declare no conflicts of interest, real or apparent, with any product or service mentioned in this report. Gembarski is employed by BCBS Michigan; Couto is employed by Cigna; Wilson is employed by HealthCore, a wholly owned subsidiary of Anthem; and Eichenbrenner is employed by the AMCP Foundation.

Figures

FIGURE 1
FIGURE 1
Methods
FIGURE 2
FIGURE 2
Employer Type of Survey Respondents and AMCP Members
FIGURE 3
FIGURE 3
Areas with Greatest Research-Related Needs, as Selected by Survey Respondents
FIGURE 4
FIGURE 4
Research Agenda and Prioritization Strategy

References

    1. Cournoyer A. Payer survey: new findings on formulary decision making. Precision for Value. February 2018. Available at: http://www.precisionallaccess.com/external-data-and-formulary-decision-m.... Accessed January 29, 2020.
    1. American College of Clinical Pharmacy. The research agenda of the American College of Clinical Pharmacy. Pharmacotherapy. 2007;27(2):312-24. Available at: https://onlinelibrary.wiley.com/doi/pdf/10.1592/phco.27.2.312. Accessed January 29, 2020. - DOI - PubMed
    1. Institute of Medicine, Roundtable on Value & Science-Driven Health Care. Appendix C: Comparative effectiveness research priorities: IOM recommendations (2009). In: Learning What Works: Infrastructure Required for Comparative Effectiveness Research: Workshop Summary. Washington, DC: National Academies Press; 2011. Available at: https://www.ncbi.nlm.nih.gov/books/NBK64788/. Accessed January 29, 2020.
    1. Academy of Managed Care Pharmacy. Not happy with pharmacy research? Let’s build a list of research priorities together! Webinar. October 22, 2014. Available at: https://www.amcp.org/Resource-Center/real-world-evidence-research/not-ha.... Accessed February 12, 2020.
    1. Reinert A, White A, Eichenbrenner P, et al. Top managed care pharmacy evidentiary gaps in 2017: a conventional content analysis. Poster presented at: AMCP Nexus 2017; October 16-19, 2017; Dallas, TX.

MeSH terms